04.07.2022 • NewsLanxessmicrobialsflavors and fragrances

Lanxess Wraps up IFF Microbial Unit Buy

German specialty chemicals producer Lanxess has wrapped up its acquisition of International Flavors & Fragrances’s microbial control business unit, a year after announcing the $1.3 billion deal with the US company in August 2021.

© Lanxess
© Lanxess

With the closing, Lanxess rises into the ranks of the world’s largest producers, significantly increasing its portfolio of antimicrobial active ingredients and formulations for material protection, preservatives and disinfectant while strengthening the Cologne-based company’s global presence, especially in the US.

Lanxess CEO Matthias Zachert said the acquisition is “another major boost” for the chemical producer’s Consumer Protection business, which will soon become its strongest segment and is “an important engine” in its stability and profitability drive.

Zachert said more than 250 “highly qualified” new employees will join Lanxess, which is now focusing its efforts on “rapidly integrating the newly acquired business” that will contribute annual sales of $450 million, along with some $100 million in EBITDA.

The transfer to Lanxess, though on schedule, required some time as the business that once belonged Dow Chemical and later to DuPont, before being sold to IFF, first had to be carved out of the flavors and fragrances group.

Author: Dede Williams, Freelance Journalist                      

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.